No Detail Found!

Identification of LncRNA CASC7/ miR-26/ ASPN/TGF-β/Smad axis in endometrial cancer

Author(s)
Xiajun Zhang Danyang People’s Hospital of Jiangsu Province, Danyang Hospital Affliated to Nantong University, Danyang, Jiangsu, China
Jie Yang Danyang People's Hospital of Jiangsu Province, Danyang Hospital Afliated to Nantong University,Danyang, Jiangsu,China
Wenjun Zhou Danyang People's Hospital of Jiangsu Province, Danyang Hospital Afliated to Nantong University,Danyang, Jiangsu,China
Zhenshi Chen Danyang People's Hospital of Jiangsu Province, Danyang Hospital Afliated to Nantong University,Danyang, Jiangsu,China
Weidong Wu Danyang People's Hospital of Jiangsu Province, Danyang Hospital Afliated to Nantong University,Danyang, Jiangsu,China
Shaoru Zhang Danyang People's Hospital of Jiangsu Province, Danyang Hospital Afliated to Nantong University,Danyang, Jiangsu,China
Lihui Wang Danyang People's Hospital of Jiangsu Province, Danyang Hospital Afliated to Nantong University,Danyang, Jiangsu,China
Abstract
Endometrial cancer is the most common gynecological malignant tumor in many countries. TGF-ß regulates cell proliferation, angiogenesis and metastasis, and is an inducer of epithelial-mesenchymal transformation. Tumor cells activate the TGF-ß/Smad pathway, and inhibiting its signal transduction pathway is an important strategy for tumor therapy. First, we have found lncRNA CASC7 is a poor prognostic marker of endometrial cancer. Then, ASPN was specifically expressed in endometrium and cell specific expression in basophils, among the most similar genes, we found TGF-ß3. Moreover, lncRNA CASC7 acts on miR-26, and miR-26 was predicted to regulate ASPN. Next, Except for SMAD2 and XIAP, the expression of ASPN, TGF-ß1, TGF-ß2, TGF-ß3, SMAD3 and SMAD4 genes in normal tissues was higher than that in tumor tissues. ASPN was positively correlated with TGF-ß1, TGF-ß2, TGF-ß3, SMAD3 and SMAD4. Pathway activity shows ASPN and TGF-ß1 and TGF-ß3 activate EMT. Finally, we speculate that lncRNA CASC7 inhibited miR-26, inhibited ASPN, inhibited TGF-ß, and promoted XIAP, to activate SMAD/XIAP pathway, improving the survival rate and invasiveness of endometrial cancer cells. Collectively, this is the first time to describe the mechanism of lncRNA CASC7/miR-26/ASPN/ TGF-ß/Smad axis in the proliferation and invasion of endometrial cancer cells.
Publication Details
Page(s) 103-111
Published Journal: Pakistan Journal of Zoology, Volume: 55, Issue: 1, Year: 2023

Request the full text from PASTIC

Keywords
bioinformatics, Endometrial cancer, TGF-ß/Smad pathway, lncRNA CASC7, ASPN
0

Citations

0

Downloads

56

Views